(19)
(11) EP 3 906 052 A1

(12)

(43) Date of publication:
10.11.2021 Bulletin 2021/45

(21) Application number: 20702946.3

(22) Date of filing: 03.01.2020
(51) International Patent Classification (IPC): 
A61K 39/245(2006.01)
A61P 35/00(2006.01)
A61P 17/00(2006.01)
A61P 25/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/245; A61K 2039/5254; A61K 2039/55; A61K 2039/70; A61P 17/00; A61P 25/00; A61P 35/00; A61K 2039/844; A61K 2039/892
(86) International application number:
PCT/US2020/012170
(87) International publication number:
WO 2020/142677 (09.07.2020 Gazette 2020/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.01.2019 US 201916238933

(71) Applicant: Albert Einstein College of Medicine
Bronx, NY 10461 (US)

(72) Inventors:
  • HEROLD, Betsy
    Rowayton, CT 06853 (US)
  • JACOBS Jr., William
    Pelham, NY 10803 (US)
  • GONZALEZ-MUNOZ, Pablo A.
    Santiago, 7500000 (CL)
  • PETRO, Christopher
    Pleasanton, CA 94566 (US)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS